BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TPM4, P67936, 7171, ENSG00000167460
15 results:

  • 1. Molecular Screening in Anaplastic lymphoma Kinase-Positive Anaplastic Large Cell lymphoma: Anaplastic lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with tpm4-ALK fusion following failure of entrectinib.
    Wong HH; Bentley H; Bulusu VR; Anyaegbu G; Watkins J; Horan G; Hatcher H
    Anticancer Drugs; 2020 Nov; 31(10):1106-1110. PubMed ID: 32868646
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events.
    Jann JC; Streuer A; Hecht A; Nolte F; Nowak V; Danner J; Obländer J; Palme I; Lengfelder E; Platzbecker U; Hofmann WK; Flach J; Nowak D
    Leuk Lymphoma; 2020 Dec; 61(13):3066-3077. PubMed ID: 32723198
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China.
    Chen B; Cao DH; Lai L; Guo JB; Chen ZY; Huang Y; Qiu S; Lin TH; Gou Y; Ma N; Yang L; Liu LR; Wei Q
    BMC Cancer; 2020 Mar; 20(1):220. PubMed ID: 32171265
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.
    Warris LT; van den Akker ELT; Bierings MB; van den Bos C; Aarsen FK; Zwaan MC; Tissing WJE; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598548
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor.
    Wang X; Krishnan C; Nguyen EP; Meyer KJ; Oliveira JL; Yang P; Yi ES; Erickson-Johnson MR; Yaszemski MJ; Maran A; Oliveira AM
    Hum Pathol; 2012 Nov; 43(11):2047-52. PubMed ID: 22658521
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ALKoma: a cancer subtype with a shared target.
    Mano H
    Cancer Discov; 2012 Jun; 2(6):495-502. PubMed ID: 22614325
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy.
    Li R; Morris SW
    Med Res Rev; 2008 May; 28(3):372-412. PubMed ID: 17694547
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
    Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
    Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.
    Liang X; Meech SJ; Odom LF; Bitter MA; Ryder JW; Hunger SP; Lovell MA; Meltesen L; Wei Q; Williams SA; Hutchinson RN; McGavran L
    Am J Clin Pathol; 2004 Apr; 121(4):496-506. PubMed ID: 15080301
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.
    Lamant L; Gascoyne RD; Duplantier MM; Armstrong F; Raghab A; Chhanabhai M; Rajcan-Separovic E; Raghab J; Delsol G; Espinos E
    Genes Chromosomes Cancer; 2003 Aug; 37(4):427-32. PubMed ID: 12800156
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
    Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence.
    Cheuk W; Chan JK
    Pathology; 2001 Feb; 33(1):7-12. PubMed ID: 11280613
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TPM3-ALK and tpm4-ALK oncogenes in inflammatory myofibroblastic tumors.
    Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
    Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.